Picture of Co-Diagnostics logo

CODX Co-Diagnostics Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapContrarian

Annual cashflow statement for Co-Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-6.96-6.27-6.242.536.7
Depreciation
Deferred Taxes
Non-Cash Items4.211.371.422.916.05
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-0.6990.964-0.82-17.1-2.74
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Cash from Operating Activities-3.21-4.08-5.5328.241.1
Capital Expenditures-0.129-0.041-0.113-0.774-0.669
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.06-0.339-0.322-5.054.77
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-0.189-0.38-0.435-5.824.1
Financing Cash Flow Items-1.09-0.154-0.593-1.460
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities5.941.885.919.70.45
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2.54-2.58-0.05742.145.6

Or unlock with your email

Or unlock with your email